SNY

Sanofi ADS
D

SNY

50.730
USD
0.01
(0.02%)
Market Closed
Volume
100,340
EPS
4
Div Yield
4.02
P/E
28
Market Cap
127,189,407,794
Related Instruments
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    AZN
    AZN
    -0.290
    (-0.43%)
    66.620 USD
    BMY
    BMY
    -0.100
    (-0.18%)
    56.300 USD
    GSK
    GSK
    -0.035
    (-0.10%)
    33.430 USD
    JNJ
    JNJ
    -0.740
    (-0.50%)
    147.060 USD
    LLY
    LLY
    -32.08
    (-4.23%)
    726.07 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    NVS
    NVS
    -0.320
    (-0.33%)
    97.530 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    More
News

Title: Sanofi ADS

Sector: Healthcare
Industry: Drug Manufacturers - General
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolicarea will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.